Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

High-Performance Centrifuge

By Drug Discovery Trends Editor | August 22, 2012

The Avanti J-26S high performance centrifuge from Beckman Coulter Life Sciences combines important environmental benefits with increased BioSafety features. Coupling the J-26S with new 1-liter polypropylene bottles furthers sample security and extends the range of biopharmaceutical and research applications.

Built upon benchmark performance, the J-26S provides high speed, low heat output, imbalance tolerance and low noise, and a range of ever-expanding separations capabilities. Ergonomic design, featuring lower instrument height and hands-free door operation, remains unchanged.

Dual-system rotor recognition automatically detects which rotor is installed and prevents it from being run above its maximum rated speed, and does so without shutting down the run. Rotor library includes fixed-angle, swinging bucket, elutriation, continuous flow and zonal rotors that offer speeds as high as 26,000 rpm and rcf up to 81,800 (x g).

Application versatility is built in: the J-26S can process up to six liters of fermenter output, deliver a subcellular fraction, run 24 microplates at a time and separate live-cell populations with centrifugal elutriation.

BioCertified rotors, instruments and labware reduce microbiological aerosols, while sterilizing grade filters capture harmful aerosols that might be expelled into the lab environment.

Made of resin that incorporates 18% post-consumer recycled plastic water bottles, each centrifuge keeps approximately 7.5 pounds of post-consumer materials from entering a landfill. The resin offers impact, scratch and chemical resistance throughout its life. Non-CFC, non-ozone depleting refrigerant extends the environmental benefits.

Thick walls made of strong resin enable the new 1-liter polypropylene bottles to be used in runs at speeds up to 16,800 x g and temperatures up to 40°C, providing higher g forces and more efficient run times while protecting samples from bottle failure.

Equipped with a wide mouth that provides easy access to samples, the bottles offer more head space to prevent leakage and have a vent to release pressure. Accessories include a tool to tighten or loosen the cap, a custom spatula to simplify pellet removal and a carrier.

Beckman Coulter Life Sciences


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE